Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care
Single Dose Administration of Benzodiazepines to Reduce Distress, Pain Severity, and the Need for Opiates Both During and After Emergency Department Care
Sponsor: Maria Pacella
Terminated
It was not feasible to enroll Emergency Department patients into this protocol
Listed as NCT03756038, this PHASE2 trial focuses on Acute Pain and remains terminated or withdrawn. Sponsored by Maria Pacella, it has been updated 12 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Feb 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Feb 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
-
Apr 2020 — Jan 2021 [monthly]
Terminated PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Terminated PHASE2
-
Aug 2019 — Mar 2020 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
May 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE2
Status: Not Yet Recruiting → Active Not Recruiting
-
Feb 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Maria Pacella
- University of Pittsburgh
- University of Pittsburgh Physicians
For direct contact, visit the study record on ClinicalTrials.gov .